Compare PEN & RTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEN | RTO |
|---|---|---|
| Founded | 2004 | 1925 |
| Country | United States | United Kingdom |
| Employees | N/A | 64084 |
| Industry | Medical/Dental Instruments | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 15.4B |
| IPO Year | 2015 | N/A |
| Metric | PEN | RTO |
|---|---|---|
| Price | $330.16 | $32.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 4 |
| Target Price | ★ $357.33 | $35.00 |
| AVG Volume (30 Days) | 563.4K | ★ 1.6M |
| Earning Date | 04-22-2026 | 03-09-2026 |
| Dividend Yield | N/A | ★ 1.61% |
| EPS Growth | ★ 1155.56 | N/A |
| EPS | ★ 4.52 | N/A |
| Revenue | ★ $1,403,665,000.00 | N/A |
| Revenue This Year | $14.34 | $17.39 |
| Revenue Next Year | $13.71 | $6.25 |
| P/E Ratio | ★ $73.05 | $222.16 |
| Revenue Growth | ★ 17.50 | N/A |
| 52 Week Low | $221.26 | $19.60 |
| 52 Week High | $362.41 | $33.47 |
| Indicator | PEN | RTO |
|---|---|---|
| Relative Strength Index (RSI) | 37.87 | 59.87 |
| Support Level | $302.19 | $30.95 |
| Resistance Level | $338.99 | $33.46 |
| Average True Range (ATR) | 2.36 | 0.71 |
| MACD | -0.76 | 0.09 |
| Stochastic Oscillator | 30.47 | 97.50 |
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in over 90 countries, with its largest operations in the United States following the acquisition of Terminix. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.